N-myc downstream regulated gene 1 (NDRG1) plays a variety of roles in human cancers. Our previous studies showed that NDRG1 expression is elevated in non-small cell lung cancer and contributes to cancer growth. However, its function in apoptosis and chemoresistance in malignant tumors, including lung cancer, is not yet fully understood. In this study, we investigated the roles of NDRG1 in chemoresistance to cisplatin in lung cancer cells. We found that overexpression of NDRG1 significantly reduced cisplatin-induced cytotoxicity in lung cancer A549 cells, while overexpression of activating transcription factor 3 (ATF3), a stress-inducible gene found to be associated with apoptosis in some human cancers, significantly promoted cytotoxicity (P < 0.05). Further investigation showed that overexpression of NDRG1 significantly downregulated ATF3 and P53 expression in A549 cells, while overexpression of ATF3 significantly upregulated P53 expression (P < 0.05). In addition, cisplatin significantly upregulated ATF3, phospho-P53(ser46), and cleaved caspase 3 expression in lung cancer cells, but overexpression of NDRG1 in the presence of cisplatin reduced the level of these proteins elevated by cisplatin (P < 0.05). While, overexpression of ATF3 significantly promoted the cytoxicity induced by cisplatin in 1299 cells (p<0.05) (Figure 4 ), but overexpression of NDRG1 didn't regulate the cytoxicity induced by cisplatin (p>0.05). These results indicate that NDRG1 may contribute to cisplatin-resistance in lung cancer, possibly due to its function in the regulation of ATF3 expression.
Introduction
The functions of N-myc downstream regulated gene 1 (NDRG1) in malignant tumors remain controversial [1] [2] [3] [4] [5] [6] . It was identified as a metastasis suppressor in some cancers [4, 6] , but other studies have found that it can promote cancer growth and metastasis [1, 3, 5] . A few studies have also indicated its possible association with cell apoptosis, but the mechanism involved remains unknown [7] [8] [9] [10] [11] [12] . NDRG1 was also reported to be involved in the regulation of cancer cell cytotoxicity induced by some anticancer agents, but the functions reported were contradictory and the associated mechanism was not elucidated [7, 8, 10, 11] . ATF3, a stress-inducible gene, was also reported to play important roles in the regulation of cell apoptosis in some cancers and was associated with chemosensitivity [13] [14] [15] [16] . A study by Bandyopadhyay et al. identified ATF3 as a downstream target of NDRG1 in prostate cancer cells [17] . However, the roles of these two proteins, and their interaction in cisplatin-chemoresistance in lung cancer cells, remain unclear. In this study, we investigated the role of NDRG1 in the regulation of chemosensitivity to cisplatin in lung cancer, and the possible role of ATF3.
Materials and Methods

Cell culture, transfection and cisplatin treatment
Human bronchial epithelial (HBE) cells and lung
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International Publisher carcinoma cell lines were cultured in RPMI 1640 tissue culture medium (Invitrogen, Carlsbad, CA, USA), containing 10% fetal calf serum (Invitrogen), 100 IU/mL penicillin (Sigma, St Louis, MO, USA), and 100 μg/mL streptomycin (Sigma) at 37°C in a humidified atmosphere (5% CO2, 95% air). The cells were cultured in a 24-well plate for 24 h before transient transfection. Cells were then transfected with Lipofectamine 3000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The cells were harvested 48 h after transfection to measure the protein levels. To examine the effect of cisplatin on cancer cells, the cells were treated by cisplatin (50μM) for 24 h.
Western blotting
Cells were lysed in 10 volumes (w/v) of lysis buffer. After centrifugation, the supernatants were collected and quantified. The same amount of total protein was separated by 10% SDS-PAGE and then transferred to PVDF membranes. The membranes were then incubated overnight at 4°C with rabbit anti-human NDRG1 polyclonal antibody (ab63989, Abcam, HK; dilution 1:500), mouse anti-human ATF3 monoclonal antibody (sc-81189, Santa Cruz, USA; dilution 1:200), phospho-P53(ser46) antibody (2521, Millipore, CA; 1:500), P53 antibody (9282, Millipore, CA; 1:500), cleaved caspase 3 antibody (9664, Millipore, CA; 1:500), and mouse anti-human β-actin polyclonal antibody (ab20272, Abcam, HK; 1:500). After incubation with appropriate secondary antibodies labelled with HRP at room temperature for 2 h, protein bands were visualized using enhanced chemiluminescence (ECL) and detected using a BioImaging System.
Immunofluorescent staining
Cells were fixed with 4% paraformaldehyde and then blocked with 1% BSA, followed by incubation with rabbit anti-human NDRG1 polyclonal antibody (ab63989, Abcam, HK; dilution 1:100) and mouse anti-human ATF3 monoclonal antibody (sc-81189, Santa Cruz, USA; dilution 1:100) overnight at 4°C. The cells were then incubated with secondary antibodies conjugated to rhodamine/fluorescein isothiocyanate (FITC). The nuclei were counterstained with DAPI and the cells were examined with an Olympus IX51 fluorescence microscope (Olympus, Tokyo, Japan). Images were captured with a CoolPIX 5400 camera (Nikon, Japan).
Cell apoptosis and necrosis detection
Cell apoptosis and necrosis detection was performed with an AnnexinV-FITC/propidium iodide (PI) apoptosis detection kit (KeyGEN BioTECH Corp., Ltd, Jiangsu, China) according to the manufacturer's instructions. Cells were harvested using 0.25% trypsin 48 h after transfection and Annexin V/FITC and PI were added after washing twice with chilled PBS and resuspension in 250 μl of binding buffer. The cells were analyzed by FACSCalibur flow cytometer (Becton Dickinson, USA) after incubation for 30 min. Cells negative for both Annexin V and PI were considered viable. Cells showing Annexin V+/PI-were indicative of early apoptosis. Cells showing Annexin V+/PI+ were indicative of late apoptosis and necrosis.
Statistical analysis
SPSS statistical software package version 13.0 (SPSS Inc., Chicago, IL, USA) was used for the analyses. All data were expressed as means ± standard deviation (SD) of at least 3 in vitro experiments. Statistical significance was tested using an independent-samples t-test to compare data between two groups. P-values of <0.05 were considered statistically significant.
Results
NDRG1 and ATF3 show opposing effects on cisplatin-induced cytotoxicity in lung cancer cells
First, we examined NDRG1 and ATF3 expression using western blot and immunofluorescent staining in lung and lung cancer cell lines ( Figure  1A ). We selected A549 and H1299 cells to investigate the function of NDRG1 and ATF3 in vitro. Moderate levels of NDRG1 and ATF3 expression were observed in A549 cells and NDRG1 and ATF3 expression in H1299 cells was very low ( Figure 1A ). Immunofluorescent staining shows that ATF3 was located in cytoplasm and nuclear in both A549 and 1299 cells, while NDRG1 was located in cytoplasm and nuclear in 1299 cells, and mainly in cytoplasm with weak expression in nuclear in A549 cells ( Figure  1B) . Overexpression of NDRG1 and ATF3 in cancer cells by transfection of specific plasmids was confirmed by western blot (Figure 2 ). We examined cisplatin-induced cytotoxicity (cell apoptosis and necrosis) of lung cancer cells using Annexin V/PI double staining. Overexpression of NDRG1 significantly reduced the cytotoxicity to lung cancer A549 cells induced by cisplatin, while overexpression of ATF3 significantly promoted cytotoxicity (p<0.05) (Figure 3) . While, overexpression of ATF3 significantly promoted the cytoxicity induced by cisplatin in 1299 cells (p<0.05) (Figure 4 ), but overexpression of NDRG1 didn't show a significant impact on the cytoxicity induced by cisplatin (p>0.05) (Figure 4) . 
NDRG1 regulates cisplatin-induced expression of ATF3, phospho-P53 (ser46), and cleaved caspase 3 in lung cancer cells
We further examined the function of NDRG1 in the regulation of ATF3 expression. Overexpression of NDRG1 significantly downregulated ATF3 and P53 expression in A549 cells (p < 0.05) (Figure 5) . Overexpression of ATF3 significantly upregulated P53 expression (P < 0.05) but did not affect NDRG1 expression in A549 cells (P > 0.05) ( Figure 5 ). While, in H1299 cells which has no P53 expression, overexpression of ATF3 didn't significantly regulate P53 and NDRG1 expression (p>0.05). These data indicate that the function of NDRG1 associated with chemoresistance is at least partly dependent on ATF3 in A549 cells. In H1299 cells, the function of ATF3 associated with chemoresistance is independent on P53. In addition, cisplatin significantly upregulated ATF3, phospho-P53(ser46), and cleaved caspase 3 expression in A549 cells, but overexpression of NDRG1 with addition of cisplatin reduced the elevated level of these proteins ( Figure 6 ) (P < 0.05). These results indicate that NDRG1 may contribute to chemoresistance to cisplatin by lung cancer cells through regulation of ATF3 and P53 in A549 cells.
Discussion
NDRG1 is induced by hypoxia and cell differentiation signals [18] . It has also been found to suppress tumor metastasis in some human cancers [4, 6] . However, the role of NDRG1 in cancer cannot be generalized. There are also some studies show that it may play cancer-promoting roles, such as promotion of tumor growth and metastasis [1, 3, 5] . According to these data, NDRG1 may have a variety of functions under different conditions and in different tumors. NDRG1 has also been linked to apoptosis and chemosensitivity in some malignant tumors [7] [8] [9] [10] [11] [12] . However, the mechanism involved was not fully elucidated. In this study, we found that overexpression of NDRG1 in lung cancer A549 cells significantly downregulated cisplatin-induced cytotoxicity. Our previous study showed that NDRG1 expression is elevated in non-small cell lung cancer and associated with cancer growth. Further studies have also shown that NDRG1 expression is increased in some other malignant tumors, such as malignant thyroid neoplasms [19] and hepatocellular carcinoma [20] . Thus, it is important to understand the mechanism and function of NDRG1 in chemotherapy-induced cytotoxicity of cancer cells to improve chemosensitivity.
ATF3 belongs to the ATF/cyclic AMP response element-binding (ATF/CREB) family [21] . It has been found to play a variety of functions including regulation of metastasis, apoptosis, and proliferation in human cancers [21, 22] . Bandyopadhyay et al. showed that ATF3 is a downstream target of NDRG1 in prostate cancer cells [17] . Our study shows that NDRG1 can also downregulate ATF3 expression in lung cancer A549 cells. But the regulation of ATF3 by NDRG1 in H1299 cells was not significant, which may be because the expression level of ATF3 in H1299 cells was very low. Here we found that overexpression of ATF3 significantly upregulated cisplatin-induced cytotoxicity in both A549 and H1299 lung cancer cells. But overexpression of NDRG1 significantly downregulated chemosensitivity to cisplatin in lung cancer A549 cells, but not in H1299 cells. It may be because NDRG1 does not significantly regulate ATF3 in H1299 cells. Further we found that NDRG1 could inhibit the promotion of cisplatin-induced cytotoxicity by ATF3 in lung cancer cells. These results indicate that ATF3 may be involved in the mechanism of NDRG1 regulation of chemosensitivity to cisplatin in lung cancer, although further investigation is still needed to clarify the mechanism including how NDRG1 regulates ATF3 and how ATF3 regulates the apoptosis pathway induced by cisplatin. Cisplatin significantly upregulated ATF3, phospho-P53(ser46), and cleaved caspase 3 expression in A549 cells, but overexpression of NDRG1 with addition of cisplatin reduced the level of elevation of these proteins (*P < 0.05).
